Evolution of the Average Target: Metro Inc.

Evolution of the Target Price: Metro Inc.

Changes in Analyst Recommendations: Metro Inc.

59c38dc3efc.aqjXYB0ZqPz2j5HNNyaipYfzS--e0WW10rdHAfIey0s.JdyzJ3pt5rus7eKrWnHD1bLCOKH_4Q_-5tQhcqcrrgAF8JAhZ0vitb_HyA~236adfb8bb8eece8d44ec83c5aa3d642
Analyst recommendations: Mondi, Admiral, Severn Trent, Coinbase, Verizon, Moderna… 29/01Zonebourse
Analyst recommendations: At&T, Caterpillar, Coinbase, Verizon, Moderna… 29/01Zonebourse
Metro Price Target Raised to $99 at TD 15/01 MT
Loblaw Price Target Raised to $217 at RBC 09/12 MT
Metro Price Target Raised to $91 at CIBC 21/11 MT
National Bank Raises Metro Price Target to $85, Maintains Sector Perform, as Previews Q3 06/24/06 MT
RBC Raises Price Target on Top Pick Loblaw 23/24/23 MT
Metro Price Target Raised to $78 at TD 31/24/31 MT
Loblaw and George Weston Price Targets Raised at TD 11/24/11 MT
Metro Price Target Lowered to $76 at TD 17/23/17 MT
Loblaw Price Target Lowered to $170 at RBC, Remains Top Idea 16/23/16 MT
Analyst recommendations: Abbvie, Burberry, Chevron, Cisco, M&S... 16/23/16Zonebourse
RBC Raises Price Target on Four Canadian Grocers, Says Loblaws Best Positioned 06/23/06 MT
Metro Q3 Results Receive Positive Analyst Reaction 09/23/09 MT
Metro Price Target Raised to $80 at TD 20/23/20 MT
Metro Inc. Price Target Raised to $80 at RBC Ahead of Q1 Results 19/23/19 MT
Desjardins Raises Price Targets on Loblaw, Metro, George Weston and Couche-Tard 16/22/16 MT
National Bank on Metro's Q3; Raises Target to $79, Maintains Sector Perform 18/22/18 MT
ATB Raises Price Targets on Loblaw, Metro Ahead of Results 09/22/09 MT
Loblaw and Metro Should Outperform in Near Term, Desjardins Says 21/22/21 MT
BMO Capital Keeps Outperform, $78 TP on Metro After Q2 22/22/22 MT
Analysts Raise Price Targets on Metro Following Q2 Results 22/22/22 MT
Metro Price Target Raised to $68 at ATB Ahead of Q1 Results 20/22/20 MT
Loblaw Shares Should Outperform Peers Following Q3 Results, TD Says 17/21/17 MT
Analyst recommendations: Amazon, Barclays, Comcast, Next, Pfizer... 30/21/30Zonebourse
More recommendations

Consensus (Composite) Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Ecart obj. / dr
-1.63%
+14.89%
+3.15%
+4.37%
+3.59%
+2.67%
-0.11%
-9.02%
+5.35%
+5.22%
Average +2.85%
Weighted average by Cap. +11.23%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
104.80CAD
Average target price
103.09CAD
Spread / Average Target
-1.63%
High Price Target
112.00CAD
Spread / Highest target
+6.87%
Low Price Target
77.00CAD
Spread / Lowest Target
-26.53%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

TD Securities
RBC Capital Markets
CIBC World Markets
National Bank
BMO Capital
ATB Capital
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings

Quarterly revenue - Rate of surprise